These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 13725438)

  • 1. [Clinical results of administration of the Bulgarian antitubercular agent no. 17].
    DZHUROV G
    Suvr Med (Sofiia); 1961; 12(1)():51-61. PubMed ID: 13725438
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitubercular isonicotinoyl hydrazones].
    DZHUROV G
    Suvr Med (Sofiia); 1961; 12(2)():155-62. PubMed ID: 13725437
    [No Abstract]   [Full Text] [Related]  

  • 3. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and in vitro and in vivo antimycobacterial activity of isonicotinoyl hydrazones.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4502-5. PubMed ID: 16115763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of new antituberculosis agents: receptor-independent four-dimensional quantitative structure-activity relationship analysis of a set of isoniazid derivatives.
    Pasqualoto KF; Ferreira EI; Santos-Filho OA; Hopfinger AJ
    J Med Chem; 2004 Jul; 47(15):3755-64. PubMed ID: 15239654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fullerene isoniazid conjugate--a tuberculostat with increased lipophilicity: synthesis and evaluation of antimycobacterial activity.
    Kumar A; Patel G; Menon SK
    Chem Biol Drug Des; 2009 May; 73(5):553-7. PubMed ID: 19366360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and experimental studies on isoniazid glucuronoside as tuberculostatic].
    SUDHOF H; KROGER E; KELLNER H
    Dtsch Med Wochenschr; 1957 May; 82(18):722-8; passim. PubMed ID: 13437800
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of immediate results of isoniazid and metazid therapy of tuberculous patients in sanatoria].
    UTKIN VV
    Probl Tuberk; 1957; 35(4):29-35. PubMed ID: 13453393
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis.
    Swamy BN; Suma TK; Rao GV; Reddy GC
    Eur J Med Chem; 2007 Mar; 42(3):420-4. PubMed ID: 17112641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Organization of tuberculosis chemoprophylaxis in Belorussian SSR].
    KOMAR TV
    Probl Tuberk; 1963; 41(2)():3-5. PubMed ID: 14034462
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of isoniazid (INH) on the hematocrit of the lizard, Uromastix hardwickii.
    Ahmad M; Ahmad M; Hasan R; Qureshi A
    Pak J Pharm Sci; 2005 Jan; 18(1):52-4. PubMed ID: 16431384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pulmonary tuberculosis with high dosage of isoniazid derivative (Na-methansulfonate-IHMS) combined with PAS. The results of primary treatment of infiltrative caseous lesions].
    OHSATO T
    Kekkaku; 1960 Oct; 35():668-74. PubMed ID: 13730529
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of different methods of treatment of tuberculous meningitis in children and their effect on the character of further complications].
    SOKLAKOVA VS
    Zdravookhranenie Kazakhstana; 1963; 23(2)():53-5. PubMed ID: 13989903
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antituberculous activity of crotonylidene-isoniazid].
    LESPAGNOL A; GERNEZ-RIEUX C; BEERENS H; TACQUET A
    Therapie; 1959; 14(2):313-23. PubMed ID: 13647448
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemical structure and antibacterial action of isoniazid analogs].
    KAKIMOTO S; KRUEGER-THIEMER E; WEMPE E
    Arzneimittelforschung; 1960 Dec; 10():963-7. PubMed ID: 13750826
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-experimental studies of the toxicity of isoniazid as compared with its methanesulfonate derivative].
    BOLLETTI M; SPARTA D
    Pediatria (Napoli); 1959; 67(3):357-82. PubMed ID: 13674789
    [No Abstract]   [Full Text] [Related]  

  • 18. [First clinical observation on the use of the isonicotinoylhydrazone of 2-furyl methyl ketone in osteoarticular tuberculosis].
    PARENTI G
    Minerva Ortop; 1961 May; 12():325-9. PubMed ID: 13732767
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isoniazid-induced pleuro-pericarditis].
    Jouneau S; Volatron AC; Brinchault G; Morel V; Belleguic C; Delaval P
    Rev Pneumol Clin; 2003 Dec; 59(6):357-9. PubMed ID: 14745341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of isonicotinoylhydrazones on isoniazid-induced disruption of ecological oxidative balance.
    Georgieva N; Gadjeva V
    Med Hypotheses; 2005; 64(3):662. PubMed ID: 15617885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.